Trial Profile
Effiacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: A retrospective cohort study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2017
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 30 Aug 2017 Results presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
- 07 Jun 2017 New trial record
- 16 May 2017 Results presented at the 112th Annual Meeting of the American Urological Association